KIMS Signs O&M and Call Option Agreements with Aurevia Hospitals
KIMS has signed an Operations and Management Agreement and a Call Option Agreement with Aurevia Hospitals Private Limited (AHPL). KIMS will manage Arete Hospitals for an initial 5-year term, receiving 9% of Net Revenue. The Call Option Agreement allows KIMS to acquire the business if suitable.
The agreement expands KIMS' operational reach and revenue streams through management fees, and the call option provides a potential future acquisition opportunity, indicating medium-term strategic growth.
The agreement is positive as it expands KIMS' operational footprint and management expertise in a growing market, with a clear revenue sharing model and a future acquisition option.
Krishna Institute of Medical Sciences Limited (KIMS) has entered into an Operations and Management (O&M) Agreement with Aurevia Hospitals Private Limited (AHPL), formerly known as Golden Lan Solution Private Limited. This agreement is for an initial term of 5 years, with an option for a further 5-year extension on an exclusive basis.
Under the O&M agreement, KIMS will be responsible for running, managing, operating, directing, and controlling the Arete Hospitals, which AHPL acquired via a Business Transfer Agreement (BTA) dated July 3, 2026. KIMS will provide medical services at Arete Hospitals. In consideration for these services, KIMS is entitled to a revenue fee of 9% of the total Net Revenue of the Hospital. Net Revenue is defined as gross revenue billed to the patient minus any concessions and discounts offered.
Furthermore, KIMS has also entered into a Call Option Agreement with AHPL. This agreement grants KIMS the option, but not the obligation, to acquire the business of Arete Hospitals if deemed suitable, subject to the terms and conditions outlined in definitive documents. The hospital has an installed capacity of approximately 250 beds and is located in Gachibowli, Hyderabad. This strategic move is expected to enhance KIMS' presence in Hyderabad, a region with significant growth potential, while AHPL benefits from KIMS' expert management.
What to do with a filing like this
Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under strategic partnerships. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.